This initiative is in response to the FDA guidance “Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During a Pandemic” that was published on March 20, 2020. The purpose of this exercise is to simplify and facilitate the collection of data on treatment outcomes and adverse drug events for approved drugs and biologics and investigational products that are used to treat COVID-19.COVID-19 Survey
ACRES systems solutions address the complexity of the research enterprise and its problems including economics, patient accessibility, globalization, regulatory burdens and ethical issues. ACRES is:
ACRES provides leadership and an “engine” for initiatives necessary to build and implement:
ACRES global system and ongoing feedback mechanisms overcomes challenges in medicines development. This systems approach:
ACRES collaboration is overcoming today's challenges in clinical research. Its objectives include:
ACRES is a multi-stakeholder collaboration building a global system for excellence in clinical research and a global network to connect sponsors, regulators, service providers, ethics committees, research sites and patient subjects with an ability to use information seamlessly and securely to benefit all stakeholders.